Related Experiment Videos
Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?
Eun Jung Chang1, Eun Ji Choi1, Kyung Hoon Kim1
1Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University, Yangsan, Korea.
The Korean Journal of Pain
|July 15, 2016
Summary
Tapentadol offers rapid pain relief for acute and chronic pain due to its dual action as a µ-opioid receptor (MOR) agonist and norepinephrine reuptake inhibitor (NRI). However, concerns regarding abuse and dependence require careful management.
Area of Science:
- Pharmacology
- Pain Management
- Neuroscience
Background:
- Tapentadol is an oral analgesic with a unique dual mechanism of action.
- It acts as both a µ-opioid receptor (MOR) agonist and a norepinephrine reuptake inhibitor (NRI).
Purpose of the Study:
- To review the pharmacological profile, efficacy, and safety of tapentadol.
- To highlight its dual action in managing different types of pain.
- To address concerns regarding its abuse potential and dependence.
Main Methods:
- Review of existing literature on tapentadol's pharmacodynamics and pharmacokinetics.
- Analysis of clinical data regarding efficacy and adverse events.
- Assessment of safety considerations and potential risks.
Main Results:
- Tapentadol provides rapid analgesia for nociceptive pain (MOR agonism) and neuropathic pain (NRI activity).
- It is rapidly absorbed and primarily excreted as glucuronidated metabolites.
- Common adverse reactions include nausea, dizziness, vomiting, and somnolence.
Conclusions:
- Tapentadol effectively treats both nociceptive and neuropathic pain.
- Careful consideration of its abuse and dependence potential is crucial for safe use.
- Further research is needed for specific populations like pregnant women and pediatric patients.